Clarifying the Term: What Are GPL Meds, and Why Does Everyone Mean GLP-1?
•
4 min read
Over 22,966 cases related to GLP-1 agonist exposure were managed by America's Poison Centers between 2019 and 2025, highlighting the prevalence and potential risks of these medications when misused. The term “GPL meds” is not a recognized medical or pharmacological abbreviation, and users searching for it are almost certainly intending to find information on GLP-1 (Glucagon-Like Peptide-1) receptor agonist medications, a class of drugs with significant clinical use. This article will clarify this common misconception and provide a comprehensive overview of what GLP-1 medications are, how they work, and their key applications.
